Skip to search formSkip to main contentSkip to account menu

tetomilast

Known as: 6-(2-(3,4-diethoxyphenyl)thiazol-4-yl)-pyridine-2-carboxylic acid 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

OPC-6535

Broader (1)

Thiazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Tetomilast suppressed production of proinflammatory cytokines from human monocytes and ameliorated chronic colitis in IL-10-deficient mice(要約)
2014
2014
Therapeutic agent for severe asthma
  • 尚 長本直児 木村孝則 殊才惠子 烏谷徳雄 神田
  • 2014
  • Corpus ID: 204049632
Provided is a drug that is useful in treating severe asthma. A therapeutic agent for severe asthma, said agent comprising… 
2007
2007
Medical Management of Ulcerative Colitis in 2006: What's on the Horizon?
According to Langholz et al., at any time, only 50% of patients with ulcerative colitis are in symptomatic remission (1). One… 
2007
2007
Novel tetomilast crystal, manufacturing method and pharmaceutical compositions of the crystalline
2006
2006
The Effect of Tetomilast (OPC-6535) on Cultured Human Vascular Endothelial Cells: 1077
2006
2006
Tetomilast (OPC-6535): A Novel Inhibitor of Human CD4 T Cell Proliferation and Interferon-γ Release
2006
2006
Tetomilast (OPC-6535) Protects Against Reactive Oxygen Species-Induced Cell Injury Independent of Phoshodiesterase Type 4 Inhibition: 1076
2004
2004
Tetomilast: Treatment of inflammatory bowel disease treatment of COPD antioxidant PDE4 inhibitor
Reactive oxygen species released by activated neutrophils are involved in the inflammatory response of tissues, and thus have a…